日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sex differences in relapse-independent and relapse-associated disability progression in relapsing-remitting multiple sclerosis: a real-world inverse-probability weighted study

复发缓解型多发性硬化症中与复发无关和与复发相关的残疾进展的性别差异:一项真实世界逆概率加权研究

Foschi, Matteo; Marastoni, Damiano; Panzera, Ivan; Mancinelli, Luca; Ganino, Cristiana; Abbadessa, Gianmarco; D'Anna, Lucio; Gabriele, Francesca; Sacco, Simona; Signoriello, Elisabetta; Lugaresi, Alessandra; Tsantes, Elena; Piscaglia, Maria Grazia; Surcinelli, Andrea

Double-negative NMOSD: from case report to a proposed diagnostic and therapeutic algorithm

双阴性视神经脊髓炎谱系疾病:从病例报告到诊断和治疗方案的提出

Romano, Giuseppe; Lus, Giacomo; Cirillo, Mario; Coppola, Cinzia; Bonavita, Simona; Signoriello, Elisabetta

Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients' Blood

探索轻度认知障碍患者血液中循环的长链非编码RNA

De Felice, Bruna; Coppola, Cinzia; Bonavita, Simona; Signoriello, Elisabetta; Montanino, Concetta; Farinella, Federica

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients

肿瘤/基质 CXCR4-CXCL12-CXCR7 在 MITO16A/MaNGO-OV2 晚期卵巢癌患者中的生物学作用

Crescenzo D'Alterio, Anna Spina, Laura Arenare, Paolo Chiodini, Maria Napolitano, Francesca Galdiero, Luigi Portella, Vittorio Simeon, Simona Signoriello, Francesco Raspagliesi, Domenica Lorusso, Carmela Pisano, Nicoletta Colombo, Gian Franco Zannoni, Nunzia Simona Losito, Rossella De Cecio, Giosuè

Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab

解整合素和金属蛋白酶 17 (ADAM17) 表达作为接受一线治疗加贝伐单抗治疗的卵巢癌患者预后标志物的分析

Marina Fabbi, Delfina Costa, Daniela Russo, Laura Arenare, Gabriele Gaggero, Simona Signoriello, Giovanni Scambia, Carmela Pisano, Nicoletta Colombo, Nunzia Simona Losito, Gilberto Filaci, Anna Spina, Daniela Califano, Giosuè Scognamiglio, Angiolo Gadducci, Delia Mezzanzanica, Marina Bagnoli, Silvan

Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study

评估血管生成相关基因作为贝伐单抗治疗卵巢癌患者的预后生物标志物:IV 期 MITO16A/ManGO OV-2 转化研究的结果

Daniela Califano, Daniela Gallo, Gian Luca Rampioni Vinciguerra, Rossella De Cecio, Laura Arenare, Simona Signoriello, Daniela Russo, Gabriella Ferrandina, Francesca Citron, Nunzia Simona Losito, Piera Gargiulo, Vittorio Simeon, Giovanni Scambia, Sabrina Chiara Cecere, Marco Montella, Nicoletta Colo